• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2100105 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2021-02-02 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2021-03-09 view
JYHB2100088 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2021-01-22 Pharmacyclics LLC Pharmacyclics Inc In Review 2021-01-21 view
JYHB2001826 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2020-09-19 Pharmacyclics LLC Pharmacyclics Inc In Review 2020-09-18 view
JYHB2000345 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2020-04-10 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2020-06-12 view
JYHB2000627 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2020-05-25 Pharmacyclics LLC Pharmacyclics Inc Filed 2020-06-04 view
JYHB2000254 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2020-03-14 Pharmacyclics LLC Pharmacyclics Inc Filed 2020-03-26 view
JYHB1900652 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(2.4) Supplementary Application 2019-06-03 Janssen Research & Development, LLC Janssen Research & Development LLC In Review 2019-06-01 view
JYHB1900651 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(2.4) Supplementary Application 2019-06-03 Janssen Research & Development, LLC Janssen Research & Development LLC In Review 2019-06-01 view
JYHB1900203 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2019-02-22 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2019-04-04 view
JYHB1800207 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(5.1) Supplementary Application 2018-03-05 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2018-11-09 view
JXHL1800070 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(2.4) Import Drug Application 2018-06-28 Janssen Research & Development, LLC Janssen Research & Development LLC Certificate Issued 2018-10-16 view
JYHB1701213 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(5.1) Supplementary Application 2017-09-26 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2018-07-06 view
JYHB1701174 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2017-09-18 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2018-04-18 view
JXHL1700019 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(2.4) Import Drug Application 2017-02-17 Janssen Research & Development, LLC Janssen Research & Development LLC Certificate Issued 2017-11-08 view
JYHB1701171 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2017-09-11 Pharmacyclics LLC Pharmacyclics Inc Filed 2017-09-25 view
JXHS1600066 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(5.1) Import Drug Application 2016-11-07 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2017-08-28 view
CXHL1502219 依鲁替尼胶囊 ibrutinib Capsule Chemical Drugs(3.1) New Drug Application 2016-03-11 哈尔滨珍宝制药有限公司 Harbin Zhenbao Pharmaceutical Co Ltd Certificate Issued 2017-03-15 view
CXHL1502114 依鲁替尼胶囊 ibrutinib Capsule Chemical Drugs(3.1) New Drug Application 2016-02-25 上海汇伦江苏药业有限公司 Shanghai Huilun (Jiangsu) Pharmaceutical Co Ltd Certificate Issued 2017-03-07 view
CXHL1502244 依鲁替尼胶囊 ibrutinib Capsule Chemical Drugs(3.1) New Drug Application 2016-02-16 浙江海正药业股份有限公司 Zhejiang Hisun Pharmaceutical Co Ltd Certificate Issued 2017-03-01 view
JXHL1300519 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Import Drug Application 2014-01-13 Pharmacyclics, Inc. Pharmacyclics Inc Certificate Issued 2016-10-28 view